Complete List of References Used in Hevert Pharmaceutical’s

Practitioner Guide for Detoxification and Drainage

  • Hodgson E. The future of human health risk assessment on environmental chemicals. Prog Mol Biol Transl Sci. 2012;112:307-322.
  • Pleil JD, Sherldon LS. Adapting concepts from systems biology to develop systems exposure event networks for exposure science research. Biomarkers. 2011;16(2):99-105.
  • Cortessis VK, Thomas DC et al. Environmental epigenetics: prospects for studying epigenetic mediation of exposure-response relationships. Hum Genet. 2012;131:1565-1589.
  • Mahadevan B, Synder RD et al. Genetic toxicology in the 21st century: reflections and future directions. Environ Mol Mutagen. 2011;52(5):339-354
  • Miller GW, Jones DP. The Nature of Nurture: Refining the Definition of the Exposome. Toxicol Sci. 2014;137(1):1-2
  • Michael Caudle W. This can’t be stressed enough: The contribution of select environmental toxicants to disruption of the stress circuitry and response. Physiol Behav. 2015;pii.S0031-9384(15)30118-9.
  • Genuis SJ. What’s out there making us sick? J Environ Public Health. 2012;2012:605137
  • Prüss-Ustün A, Vickers C et al. Knowns and unknowns of burden of disease due to chemicals: a systematic review. Environmental Health. 2011;10:9
  • Massey R, Jacobs M. Chapter 1: Trends and Indicators. United Nations Environmental Program. Global Chemicals Outlook. Towards Sound Management of Chemicals. Synthesis Report for Decision Makers 2012. http://www.unep.org/pdf/GCO_Synthesis%20Report_CBDTIE_UNEP_September5_2012.pdf (accessed May 7, 2016)
  • Scorecard, The Pollution Information Site. http://scorecard.goodguide.com/env-releases/def/ej_burdens.html (accessed May 7th, 2016)
  • National Report on Human Exposure to Environmental Chemicals, Fourth Report, 2009. Center of Disease Control and Prevention. http://www.cdc.gov/exposurereport/pdf/fourthreport.pdf (accessed May 7th, 2016)
  • Pestana D, Faria G et al. Persistent organic pollutant levels in human visceral and subcutaneous adipose tissue in obese individuals—depot differences and dysmetabolism implications. Environ Res. 2014;133:170-177.
  • Mullerova D, Kopecky J. White adipose tissue: storage and effector site for environmental pollutants. Physiol. Res. 2007;56:375-381.
  • Evans AM, Rice GE et al. Joint exposure to chemical and nonchemical neurodevelopmental stressors in U.S. women of reproductive age in NHANES. Int J Environ Res Public Health. 2014;11(4):4384-4401.
  • McEwen BS, Tucker P. Critical biological pathways for a chronic psychosocial stress and research opportunities to advance the consideration of stress in chemical risk assessment. Am J Public Health. 2011; 101 Suppl. 1:S131-139.
  • Konstandi M, Johnson EO, Lang MA. Consequences of psychophysiological stress on cytochrome P450-catalyzed drug metabolism. Neurosci Biobehav Rev. 2014;45:149-167.
  • Bondy SC. Anthropogenic pollutants may increase the incidence of neurodegenerative disease in an aging population. Toxicol. 2016;3:341-343:41-46
  • Steenland K, Mora AM et al. Organochlorine chemicals and neurodegeneration among elderly subjects in Costa Rica. Environ Res. 2014;134:205-209.
  • Lim YH, Kim H et al. Air pollution and symptoms of depression in elderly adults. Environ Health Perspect. 2012;120:1023-1028.
  • Sartorelli P. Dermal exposure assessment in occupational medicine. Occup Med (Lond). 2002;52(3):151-156.
  • Kelly FJ, Fussell JC. Air pollution and airway disease. Clin Exp Allergy. 2011;41(8):1059-1071.
  • Brook RD, Rajagopalan S et al. Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation. 2010;121(21):2331-2378.
  • Brandt EB, Myers JM et al. Air pollution and allergic diseases. Curr Opin Pediatr. 2015;27(6):724-735.
  • Dirinck E, Jorens PG et al. Obesity and persistent organic pollutants: possible obesogenic effects of organochlorine pesticides and polychlorinated biphenyls. Obesity (Silver Spring). 2011;19(4):709-714.
  • Lee Dh, Steffes MW et al. Low dose organochlorine pesticides and polychlorinated biphenyls predict obesity, dyslipidemia, and insulin resistance among people free of diabetes. PLoS One. 2011;6(1):e15977
  • Legler J. An integrated approach to assess the role of chemical exposure in obesity. Obesity (Silver Spring). 2013;21(6):1084-1085.
  • Mullerova D, Kopecky J. White adipose tissue: storage and effector site for environmental pollutants. Physiol. Res. 2007;56:375-381.
  • La Merril M, Emond C et al. Toxicological function of adipose tissue: focus on persistent organic pollutants. Environ Health Perspect. 2013;121(2):162-169
  • Pestana D, Faria G et al. Persistent organic pollutant levels in human visceral and subcutaneous adipose tissue in obese individuals—depot differences and dysmetabolism implications. Environ Res. 2014;133:170-177.
  • Dirinck EL, Dirtu AC et al. Exposure to persistent organic pollutants: relationship with abnormal glucose metabolism and visceral adiposity. Diabetes Care. 2014;37(7):1951-1958.
  • Meyer JN, Leung MCK et al. Mitochondria as a Target of Environmental Toxicants. Toxicol Sci. 2013;134(1):1-17.
  • Nunnari J, Soumalainen A. Mitochondria: In Sickness and in Health. Cell. 2012;148:1145-1159
  • Edeas M, Weisseg V. Targeting mitochondria: strategies, innovations and challenges: The future of medicine will come through mitochondria. Mitochondria. 2013;13(5):389-390.
  • Lin S, Cho YM et al. Persistent organic pollutants, mitochondrial dysfunction, and metabolic syndrome. Ann NY Acad Sci. 2010;1201:166-176
  • Onyango IG, Dennis J, Khan SM. Mitochondrial Dysfunction in Alzheimer’s Disease and the Rationale for Bioenergetic Based Therapies. Aging Dis. 2016;7(2):201-214.
  • Nuno-Lambarri N, Barbero-Becerra VJ et al. Mitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics Approach. Int J Mol Sci. 2016;17(3):pii:E281
  • Dietert RR, Silbergeld EK. Biomarkers for the 21st century: listening to the microbiome. Toxicol Sic. 2015;144(2):208-216.
  • Pieper IA, Bertau M. Predictive tools for the evaluation of microbial effects on drugs during gastrointestinal passage. Expert Opin Drug Metab Toxicol. 2010;6(6):747-760.
  • Sousa T, Paterson R et al. The gastrointestinal microbiota as a site for the biotransformation of drugs. Int J Pharm. 2008;363(1-2):1-25.
  • Kang MJ, Kin HG et al. The effect of gut microbiota on drug metabolism. Expert Opin Drug Metabol Toxicol. 2013;9(10):1295-1308.
  • Breton J, Massart S et al. Ecotoxicology inside the gut: impact of heavy metals on the mouse microbiome. BMC Pharmacol and Toxicology. 2013;14:62
  • Lu K, Abo RP et al. Arsenic Exposure Perturbs the Gut Microbiome and Its Metabolic Profile in Mice: An Integrated Metagenomics and Metabolomics Analysis. Environ Health Perspect. 2014;122:284-291
  • Zhang L, Nichols RG et al. Persistent Organic Pollutants Modify Gut Microbiota-Host Metabolic Homeostasis in Mice Through Aryl Hydrocarbon Receptor Activation. Environ Health Perspect. 2015; 123(7):679-688.
  • Salim SY, Kaplan GG, Madsen KL. Air pollution effects on the gut microbiota: a link between exposure and inflammatory disease. Gut Microbes. 2014;5(2):215-219.
  • Comparative Toxicogenomics Network, U.S. National Library of Medicine and Toxicology Data Network. http://toxnet.nlm.nih.gov/newtoxnet/ctd.htm (accessed May 8th, 2016)
  • Rappaport SM. Biomarkers intersect with the exposome. Biomarkers. 2012;17(6):483-489.
  • Rappaport SM, Barupal DK et al. The Blood Exposome and Its Role in Discovering Causes of Disease. Environ Health Perspect. 2014;122(8):769-774.
  • Pleil JD, Stiegel MA. Evolution of Environmental Exposure Science: Using Breath-Borne Biomarkers For “Discovery” of the Human Exposome. Anal Chem. 2013;85(21):9984-9990.
  • Bijlsma N, Cohen MC. Environmental Chemical Assessment in Clinical Practice: Unveiling the Elephant in the Room. Int J Environ Res Public Health. 2016;13(2).pii: E181
  • Ingelman-Sundberg M. Genetic susceptibility to adverse effects of drugs and environmental toxicants. The role of the CYP family of enzymes. Mutat Res. 2001;482(1-2):11-19.
  • Chevrier J, Dewailly E et al. Body weight loss increases plasma and adipose tissue concentrations of potentially toxic pollutants in obese individuals. Int J Obes Relat Metab Disord. 2000;24(10):1272-1278.
  • Hue O, Marcotte J et al. Increased plasma levels of toxic pollutants accompanying weight loss induced by hypocaloric diet or by bariatric surgery. Obes Surg. 2006;16(9):1145-1154
  • Perera FP, Rauh V et al. A summary of recent findings on birth outcomes and developmental effects of prenatal ETS, PAH, and pesticide exposures. Neurotoxicology. 2005;26(4):573-587.
  • Wigle DT, Arbuckle TE et al. Epidemiological evidence of relationships between reproductive and child health outcomes and environmental chemical contaminants. J Toxicol Environ Health B Crit Rev. 2008;11(5-6):373-517.
  • Tavares RS, Escado-Rebelo S et al. The non-genomic effects of endocrine-disrupting chemicals on mammalian sperm. Reproduction. 2016;151(1):R1-R13
  • Hutz RJ, Carvan MJ et al. Environmental toxicants and effects on female reproductive function. Tren Reprod Bio. 2006;2:1-11.
  • Zama AM, Uzumcu M. Epigenetic effects of endocrine-disrupting chemicals on female reproduction: an ovarian perspective. Front Neuroendocrinol. 2010;31(4):420-439.
  • Pant N, Kumar G et al. Reproductive toxicity of lead, cadmium, and phthalate exposure in men. Environ Sci Pollut Res Int. 2014;21(18):11066-11074.
  • Pischinger A. Heine H. (ed). The Extracellular Matrix and Ground Regulation. Basis for a Holistic Biological Medicine. North Atlantic Books. 2007
  • Bissell MJ, Barcellos-Hoff MH. The influence of extracellular matrix on gene expression: is structure the message? J Cell Sci Suppl 1987;8:327-43.
  • Gieni RS, Hendzel MJ. Mechanotransduction from the ECM to the genome: are the pieces now in place? J Cell Biochem 2008;104(6):1962-87.
  • Spencer VA, Xu R, Bissell MJ. Gene expression in the Third Dimension: The ECM-nucleus connection. J Mammary Gland Biol Neoplasia 2010;15(1):65-71
  • Bissell MJ, Glenn Hall H, Parry G. How does the extracellular matrix direct gene expression. J Theor Biol. 1982;99(1):31-68
  • Xu R, Boudreau A, Bissell MJ. Tissue architecture and function: dynamic reciprocity via extra and intra-cellular matrices. Cancer Metastasis Rev 2009 ;28(1-2) :167-176.
  • Frantz C, Stewart KM, Weaver VM. The extracellular matrix at a glance. J Cell Sci. 2010;123:4195-4200.
  • Humacher D, Apte SS. The biology of the extracellular matrix: novel insights. Curr Opin Rheumatol. 2013;25(1):65-70.
  • Sorokin L. The impact of the extracellular matrix on inflammation. Nat Rev Immunol. 2010;10(10):712-723.
  • Steinberg N, Kolodkin-Gal I. The Matrix Reloaded: Probing the Extracellular Synchronizes Bacterial Communities. J Bacteriol. 2015. Pii:JB.025516-14 [Epub ahead of print].
  • Pischinger A. Heine H. (ed). The Extracellular Matrix and Ground Regulation. Basis for a Holistic Biological Medicine. North Atlantic Books. 2007

 

  • Nelson DL, Cox MM. Lehninger Principles of Biochemistry 5th edition. 2008, W.H. Freeman & Co., New York, NY p. 255
  • Spavero LJ, Asafu-Adjei D et al. RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. J Transl Med. 2009;7:17. Doi:10.1186/1479-5876-7-17
  • Ruppert SM, Hawn TR et al. Tissue integrity signals communicated by high-molecular weight hyaluronan the resolution of inflammation. Immunol Res. 2014;58(2):186-192.
  • Lardner A. The effects of extracellular pH on immune function. J Leukoc Biol. 2001;69(4):522-530.
  • Rajamaki K, Nordstrom T et al. Extracellular acidosis is a novel danger signal alerting innate immunity via the NLRPs inflammasome. J Biol Chem. 2013;288:13410-13419
  • Russell EG, Cotter TG. New Insight into the Role of Reactive Oxygen Species (ROS) in Cellular Signal-Transduction Processes. Int Rev Cell Mol Biol. 2015;319:221-254.
  • Zhang J, Wang X et al. ROS and ROS-Mediated Cellular Signaling. Oxid Med Cell Longev. 2016:430965.
  • Schultz GS, Davidson JM et al. Dynamic reciprocity in the wound microenvironment. Wound Repair Regen 2011;19(2):134-48
  • Li Q, Hata A et al. The density of extracellular matrix proteins regulates inflammation and insulin signaling in adipocytes. FEBS Lett 2010;584(19):4145-50
  • Santos AB, Junges M et al. Early change of extracellular matrix and diastolic parameters in metabolic syndrome. Arq Bras Cardiol. 2013;101(4):311-316.
  • Reizes O, Benoit SC, Clegg DJ. The role of syndecans in the regulation of body weight and synaptic plasticity. Int J Biochem Cell Biol 2008;40(1):28-45
  • Burgess JK. The role of the extracellular matrix and specific growth factors in the regulation of inflammation and remodelling in asthma. Pharmacol Ther. 2009; 12(1):19-29
  • Berk BC, Fuijiwara K et al. ECM remodeling in hypertensive heart disease. The J Clin Invest 2007;117(3):568-575
  • Iozzo RV, Sanderson RD. Proteoglycans in cancer biology, tumour microenvironment and angiogenesis. J Cell Mol Med 2011;15(5):1013-31
  • Choi I, Lee S, Hong YK. The new era of the lymphatic system: no longer secondary to the blood vascular system. Cold Spring Harb Perspect Med. 2012;2(4):a006445.
  • Liao S, von der Weid PY. Lymphatic system: an active pathway for immune protection. Semin Cell dev Biol. 2015;38:83-89.
  • Wilting J, Becker J et al. Lymphatics and inflammation. Curr Med Chem. 2009;16(34):4581-4592.
  • Brown P. Lymphatic system: Unlocking the drains. Nature. 2005;438:456-458.
  • Kmiec Z. Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol. 2001;161:III-XIII, 1-151.
  • Robinson MW, Harmon C, O’Farrelly C. Liver immunology and its role in inflammation and homeostasis. Cell Mol Immunol. 2016;13(3):267-276.
  • Adams DH, Eksteen B, Curbishley SM. Immunology of the gut and liver: a love/hate relationship. Gut 2008;57:838-848
  • Robinson MW, Harmon C, O’Farrelly C. Liver immunologcy and its role in inflammation and homeostasis. Cell Mol Immunol. 2016;13:267-276.
  • Zeuzem S. Gut-liver axis. Int J Coloreactal Dis. 2000;15(2):59-82.
  • Visschers RG, Luyer MD et al. The gut-liver axis. Curr Opin Clin Nutr Metab Care. 2013;16(5):576-581.
  • Viggiano D, Ianiro G et al. Gut barrier in health and disease: focus on childhood. Eur Rev Med Pharmacol Sci. 2015’19(6):1077-1085.
  • Odenwald MA, Turner JR. Intestinal permeability defects: is it time to treat? Clin Gastroenterol Hepatol. 2013;11(9):1075-1083.
  • De Punder K, Pruimboom L. Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability. Front Immunol. 2015;6:223
  • Thelen K, Dressman JB. Cytochrome P450-mediated metabolism in the human gut wall. J Pharm Pharmacol. 2009;61(5):541-558.
  • Murakami T, Takano M. Intestinal efflux transporters and drug absorption. Expert Opin Drug Metabol Toxicol. 2008;4(7):923-939.
  • Nakamura T, Yamamori M, Sakaeda T. Pharmacogenetics of intestinal absorption. Curr Drug Deliv. 2008;5(3):153-169.
  • Hukkanen J, Pelkonen O, Raunio H. Expression of xenobiotic-metabolizing enzymes in human pulmonary tissue: possible role in susceptibility for ILD. Eur Respir J Suppl. 2001;32:122s-126s.
  • Baron JM, Wiederholt T et al. Expression and function of cytochrome p450-dependent enzymes in human skin cells. Curr Med Chem. 2008;15(22):2258-2264
  • Gribble RM. The gut endocrine system as a coordinator of postprandial nutrient homeostasis. Proc Nutr Soc. 2012;71(4):456-462.
  • Manocha M, Khan WI. Serotonin and GI Disorders: An Update on Clinical and Experimental Studies. Clin Transl Gastroenterol. 2012;3,e13
  • Konturek SJ, Konturek PC et al. Role of melatonin in upper gastrointestinal tract. J Physiol Pharmacol. 2007;58 Suppl. 6:23-52.
  • Ahlman H. Nilsson O. The gut as the largest endocrine organ in the body. Annals of Oncology. 2001;12(Suppl. 2):S63-S68.
  • Furness JB, Rivera LR et al. The gut as a sensory organ. Nat Rev Gastroenterol. 2013;10:729-740
  • Nicholson JK, Holmes E et al. Host-Gut Microbiota Metabolic Interactions. Science. 2012;336:1262’ DOI: 10.1126/science.1223813
  • Neuman H, Debelius JW et al. Microbial endocrinology: the interplay between the microbiota and the endocrine system. FEMS Microbial Rev. 2015;39(4):509-521
  • Clarke G, Stilling RM et al. Minireview: Gut Microbiota: The Neglected Endocrine Organ. Mol Endocrinol. 2014;28(8):1221-1238
  • Tillisch K. The effects of gut microbiota on CNS function in humans. Gut Microbes. 2014;5(3):404-410
  • John Hopkins Medicine, The Brain-Gut Connection, http://www.hopkinsmedicine.org/health/healthy_aging/healthy_body/the-brain-gut-connection (accessed June 3, 2016)
  • Furness JB, Callaghan BP et al. The enteric nervous system and gastrointestinal innervation: integrated local and central control. Adv Exp Med Biol. 2014;817:39-71.

 

  • Chiu IM, von Hehn CA, Woolf C. Neurogenic Inflammation: The Peripheral Nervous System’s Role in Host Defense and Immunopathology. Nat Neurosci. 2012;15(8):1063-1067
  • Backhed F, Fraser CM et al. Defining a Healthy Human Gut Microbiome: Current Concepts, Future Directions, and Clinical Applications. Cell Host& Microbe 2012;12:611-622.
  • Grenham S, Clarke G et al. Brain-gut-microbe communication in health and disease. Front Physiol. 2011;2:04
  • Mayer EA, Tillisch K, Gupta A. Gut/brain axis and the microbiota. J Clin Invest. 2015;125(3):926-938
  • Carabotti M, Scirocco A et al. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Am Gastroenterol. 2015;28(2):203-209
  • Bauer KC, Huus KE, Finlay BB. Microbes and the mind: emerging hallmarks of the gut microbiota-brain axis. Cell Microbiol. 2016;18(5):632-644.
  • Baggio LLm Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology. 2007;132(6):2131-2157
  • McIntosh CH, Widenmaier S, Kim SJ. Pleiotropic actions of the incretin hormones. Vitam Horm. 2010;84:21-79
  • Asmar M, Holst JJ. Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: new advances. Curr Opin Endocrinol Diabetes Obes. 2010;17(1):57-62.
  • Pallagi P, Hegyo P, Rackonczay Z Jr. The Physiology and Pathophysiology of Pancreatic Ductal Secretion: The Background for Clinicians. Pancreas. 2015;44(8):1211-1233.
  • Ishiguro H, Yamamoto A et al. Physiology and pathophysiology of bicarbonate secretion by pancreatic duct epithelium. Nagoya J Med Sci. 2012;74(1-2):1-18.
  • Scarpelli DG. Toxicology of the pancreas. Toxicol Appl Pharmacol. 1989;101(3):543-554.
  • Lerch MM, Albrecht E et al. Pathophysiology of alcohol-induced pancreatitis. Pancreas. 2003;27(4):291-296.
  • Yadav D, Whitcomb DC. The role of alcohol and smoking in pancreatitis. Nat Rev Gastroenterol Hepatol. 2010;7(3):131-145.